Agilent Technologies, Inc. $A Position Cut by Impax Asset Management Group plc

Impax Asset Management Group plc trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 2.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,961,796 shares of the medical research company’s stock after selling 61,046 shares during the period. Agilent Technologies makes up about 2.2% of Impax Asset Management Group plc’s holdings, making the stock its 9th largest holding. Impax Asset Management Group plc owned about 1.04% of Agilent Technologies worth $380,147,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. Advisors Asset Management Inc. boosted its holdings in Agilent Technologies by 3.8% during the 3rd quarter. Advisors Asset Management Inc. now owns 8,799 shares of the medical research company’s stock valued at $1,129,000 after acquiring an additional 325 shares during the period. Krilogy Financial LLC acquired a new stake in shares of Agilent Technologies during the third quarter worth about $813,000. Wealthfront Advisers LLC boosted its stake in shares of Agilent Technologies by 19.9% in the third quarter. Wealthfront Advisers LLC now owns 21,370 shares of the medical research company’s stock valued at $2,743,000 after purchasing an additional 3,546 shares during the period. Candriam S.C.A. grew its holdings in shares of Agilent Technologies by 65.4% in the third quarter. Candriam S.C.A. now owns 882,230 shares of the medical research company’s stock valued at $113,234,000 after purchasing an additional 348,764 shares in the last quarter. Finally, Waterfront Wealth Inc. purchased a new stake in Agilent Technologies during the 3rd quarter worth approximately $194,000.

Analysts Set New Price Targets

Several research firms have commented on A. HSBC began coverage on shares of Agilent Technologies in a research note on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price target for the company. Bank of America boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. Wells Fargo & Company increased their price target on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $155.00 to $160.00 in a research note on Monday, January 5th. Finally, Citigroup upped their target price on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $164.50.

Agilent Technologies Stock Up 1.1%

A opened at $128.87 on Wednesday. The business’s 50-day simple moving average is $139.11 and its 200-day simple moving average is $135.37. The stock has a market capitalization of $36.45 billion, a P/E ratio of 28.20, a price-to-earnings-growth ratio of 3.70 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period last year, the firm posted $1.46 earnings per share. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th were paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date was Tuesday, January 6th. Agilent Technologies’s payout ratio is currently 22.32%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at $4,591,987.92. This trade represents a 2.76% decrease in their position. The SEC filing for this sale provides additional information.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.